Ultragenyx Pharmaceutical Overview
Ultragenyx Pharmaceutical Target Price
Analysts' 12-month price predictions for RARE.
Share Price
$43.2
Average Target Price
$127.00
194% upside
194% upside2 analysts in the last 4 months
High: $130 | Low: $124
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-15 | Stifel NicolausDae Gon Ha | $124 | 187% upside |  |
| 2024-04-15 | Raymond JamesChristopher Raymond | $130 | 200.9% upside | |
| 2023-02-03 | Morgan Stanley | $95 | 119.9% upside | |
| 2022-12-30 | H.C. Wainwright | $82 | 89.8% upside | |
| 2022-07-28 | Piper SandlerChristopher Raymond | $130 | 200.9% upside | |
| 2022-07-01 | Stifel Nicolaus | $142 | 228.7% upside | |
| 2022-05-24 | Goldman Sachs | $101 | 133.8% upside | |
| 2022-05-18 | Piper SandlerChristopher Raymond | $135 | 212.5% upside | |
| 2022-05-06 | Morgan Stanley | $109 | 152.3% upside | |
| 2022-05-06 | Leerink Partners | $115 | 166.2% upside | |
| 2022-01-10 | Cowen & Co.Yaron Werber | $124 | 187% upside | |
| 2021-11-03 | CitigroupYigal Nochomovitz | $150 | 247.2% upside | |
| 2021-11-03 | WedbushLaura Chico | $92 | 113% upside | |
| 2021-09-27 | Piper SandlerChristopher Raymond | $170 | 293.5% upside | |
| 2021-08-19 | UBSEsther Rajavelu | $73 | 69% upside | |
| 2021-08-03 | BarclaysGena Wang | $141 | 226.4% upside | |